NLR | PSIL | NLR / PSIL | |
Gain YTD | 46.029 | 62.820 | 73% |
Net Assets | 2.39B | 14.5M | 16,469% |
Total Expense Ratio | 0.56 | 0.99 | 57% |
Turnover | 36.00 | 69.00 | 52% |
Yield | 0.52 | 1.99 | 26% |
Fund Existence | 18 years | 4 years | - |
NLR | PSIL | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 3 days ago83% | 3 days ago90% |
Momentum ODDS (%) | 3 days ago90% | 3 days ago90% |
MACD ODDS (%) | 3 days ago90% | 3 days ago90% |
TrendWeek ODDS (%) | 3 days ago78% | 3 days ago90% |
TrendMonth ODDS (%) | 3 days ago80% | 3 days ago90% |
Advances ODDS (%) | 13 days ago90% | 3 days ago90% |
Declines ODDS (%) | 6 days ago75% | 19 days ago90% |
BollingerBands ODDS (%) | 3 days ago90% | 3 days ago90% |
Aroon ODDS (%) | 3 days ago89% | 3 days ago90% |
A.I.dvisor indicates that over the last year, NLR has been closely correlated with SMR. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if NLR jumps, then SMR could also see price increases.
Ticker / NAME | Correlation To NLR | 1D Price Change % | ||
---|---|---|---|---|
NLR | 100% | +0.46% | ||
SMR - NLR | 76% Closely correlated | -4.16% | ||
OKLO - NLR | 76% Closely correlated | +0.26% | ||
BWXT - NLR | 70% Closely correlated | -0.09% | ||
NNE - NLR | 68% Closely correlated | +1.64% | ||
PEG - NLR | 54% Loosely correlated | -0.75% | ||
More |
A.I.dvisor indicates that over the last year, PSIL has been closely correlated with DRUG. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if PSIL jumps, then DRUG could also see price increases.
Ticker / NAME | Correlation To PSIL | 1D Price Change % | ||
---|---|---|---|---|
PSIL | 100% | +1.56% | ||
DRUG - PSIL | 83% Closely correlated | -3.89% | ||
MNMD - PSIL | 36% Loosely correlated | -0.11% | ||
ATAI - PSIL | 30% Poorly correlated | +0.22% | ||
CMPS - PSIL | 29% Poorly correlated | +0.78% | ||
CMND - PSIL | 26% Poorly correlated | +0.93% | ||
More |